NEU NEUCA S.A.

179.67USD722.00 PLN · GPW+0.84%Mkt Cap: 812.63M USDP/E: 16.68

NEUCA S.A. engages in the wholesale distribution of pharmaceuticals in Poland. It operates through Wholesale Distribution of Medicines, Manufacture of Pharmaceuticals, Medical Operator, Clinical Trials, and Insurance Act…

Key Statistics

Company
Market Cap812.63M USD
Enterprise Value1.02B USD
Revenue (TTM)3.57B USD
Gross Profit387.80M USD
Net Income (TTM)38.72M USD
Revenue/Share779.79 USD
Last Price179.67 USD
Fiscal Year EndDec 2025
MR QuarterSep 2026
Employees5.0K
CountryPL
SectorHealthcare
IndustryMedical Distribution
ISINPLTRFRM00018
Valuation
P/E (Trailing)16.68
P/E (Forward)13.20
PEG—
EV/EBITDA10.47
EV/Revenue0.28
P/S0.23
P/B2.91
EPS (TTM)10.77 USD
EPS (Forward)13.61 USD
52W Range
160.5136% of range213.27
52W High213.27 USD
52W Low160.51 USD
Profitability
Gross Margin11.42%
Oper. Margin2.11%
EBITDA Margin2.72%
Profit Margin1.14%
ROE14.71%
ROA2.49%
ROIC14.07%
ROCE19.05%
Growth
Revenue Growth5.50%
Earnings Growth-5.20%
Cash Flow & Leverage
Operating CF136.59M USD
CapEx (TTM)31.08M USD
FCF Margin1.53%
FCF Yield6.71%
Net Debt134.09M USD
Net Debt/EBITDA1.38
Net Debt/FCF2.46
Balance Sheet
Debt/Equity0.47
Current Ratio0.91
Quick Ratio0.52
Book Value/Sh61.64 USD
Cash/Share5.16 USD
Dividends
Fwd Div Rate4.43 USD
Trail. Div Rate4.43 USD
Div. Yield2.49%
5Y Avg Yield1.76%
Payout Ratio42.43%
Ex-Div DateJun 29, 2026
Pay Date—
Analyst Consensus
Rating1.0 (Strong Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)236.77 USD
Upside (mean)+31.8%
Target Range206.55 USD – 284.94 USD
206.55+31.8% to mean284.94
# Analysts5
Ownership
Shares Out.4.52M
Float1.64M
Insiders60.55%
Institutions10.21%
Technical
SMA 50176.79 (+1.6%)
SMA 200181.32 (-0.9%)
Beta—
S&P 52W Chg8.68%
Avg Vol (30d)3.08K
Avg Vol (10d)1.04K
Technical Indicators
RSI (14)55.6
MACD-4.4247
MACD Signal-7.6003
MACD Hist.+3.1755
BB Upper179.43 USD
BB Middle174.76 USD
BB Lower170.09 USD
BB Width5.34%
ATR (14)4.041 USD
Vol Ratio (20d)2.25x

About NEUCA (WSE: NEU)

›

NEUCA (WSE: NEU) is listed on Warsaw Stock Exchange, where its shares trade in PLN. It belongs to the Medical Distribution industry, part of the Healthcare sector, and reports about 5,004 employees.

The shares were at 722.00 PLN on 20 November 2026, up 10.2% over 52 weeks. Its 52-week range is 645.00 PLN to 857.00 PLN: the price is 15.8% below the high and 11.9% above the low.

At a market capitalisation of 3.27B PLN, it trades at 16.7 times trailing earnings and 13.2 times forward earnings. The median trailing P/E of its 17 largest Medical Distribution peers is 22.9, a discount of 27% for NEU. It pays a dividend yielding 2.49% (it pays out 42% of its earnings), against a median of 1.38% among the dividend payers in that peer group.

NEUCA reports return on equity of 14.7%, an operating margin of 2.1% and revenue up 5.5% year over year.

Its debt exceeds its cash by 538.82M PLN, a debt-to-equity ratio of 0.47. Its Piotroski F-score is 4 out of 9, an average reading of its financial health. 5 analysts cover the stock, with an average rating of Strong Buy; their mean price target of 951.44 PLN is 31.8% above the current price.